2021
DOI: 10.1016/j.jcf.2021.04.006
|View full text |Cite
|
Sign up to set email alerts
|

Respiratory symptoms do not reflect functional impairment in early CF lung disease

Abstract: Background: Lung disease can develop within the first year of life in infants with cystic fibrosis (CF). However, the frequency and severity of respiratory symptoms in infancy are not known. Methods:We assessed respiratory symptoms in 50 infants with CF and 50 healthy matched controls from two prospective birth cohort studies. Respiratory symptoms and respiratory rate were documented by standardized weekly interviews throughout the first year. Infants performed multiple breath washout in the first weeks of lif… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 37 publications
0
2
0
Order By: Relevance
“…This study includes data of infants from two prospective birth cohort studies: the Swiss Cystic Fibrosis Infant Lung Development (SCILD) 17 and the Basel Bern Infant Lung Development (BILD) cohort 37 . Infants were followed throughout the first year of life 38 . Ethics Committee of the Canton of Bern, Switzerland approved the study.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…This study includes data of infants from two prospective birth cohort studies: the Swiss Cystic Fibrosis Infant Lung Development (SCILD) 17 and the Basel Bern Infant Lung Development (BILD) cohort 37 . Infants were followed throughout the first year of life 38 . Ethics Committee of the Canton of Bern, Switzerland approved the study.…”
Section: Methodsmentioning
confidence: 99%
“…We investigated 1. β-diversity: compositional microbiota differences between samples based on a dissimilarity matrix, 2. within-subject dissimilarity: β-diversity between consecutive taken swabs with less than three weeks difference of the same infant, 3. α-diversity: microbiota diversity within a sample, and 4. differential bacterial abundances (%). We assessed symptom scores as described previously 38 (Supplementary table 4). We included: a. all samples of all infants; b. samples taken before the first antibiotic treatment.…”
Section: Comparison Of the Nasal Microbiota Between Infants With Cf A...mentioning
confidence: 99%